Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EMMA | BMY | AMGN | GILD | REGN |
| Company | Emmaus Life Sciences Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4203 | 73.21 | 249.96 | 84.65 | 764.49 |
| High | 0.4400 | 74.47 | 249.96 | 86.97 | 789.95 |
| Low | 0.3800 | 72.61 | 242.21 | 83.62 | 758.63 |
| Last | 0.3800 | 74.45 | 245.17 | 84.50 | 783.13 |
| Change | -0.0305 | +1.68 | -1.36 | +3.11 | +31.93 |
| % Change | -7.43% | +2.31% | -0.55% | +3.82% | +4.25% |
| Volume | 30,400 | 10,211,800 | 3,072,900 | 12,852,400 | 1,448,500 |
| 20-Day Average Volume | 27,645 | 8,647,345 | 2,545,710 | 6,954,795 | 703,940 |
| Previous Close | 0.4105 | 72.77 | 246.53 | 81.39 | 751.20 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3707 | 72.57 | 261.08 | 84.56 | 731.22 |
| 20-Day Raw Stochastic | 30.46% | 89.42% | 21.75% | 51.47% | 94.41% |
| 20-Day Relative Strength | 51.40% | 53.22% | 30.16% | 51.17% | 63.26% |
| Weighted Alpha | -84.57 | +10.30 | +4.90 | +38.80 | +24.40 |
| Today's Opinion | 40% Buy | 16% Buy | 8% Sell | 40% Buy | 88% Buy |
| Previous Opinion | 40% Buy | 40% Sell | 8% Sell | 40% Buy | 64% Buy |
| Last Month's Opinion | 56% Sell | 24% Sell | 40% Buy | 80% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -22.45% since 01/27/23 | +2.76% since 01/27/23 | -3.34% since 01/27/23 | +0.92% since 01/27/23 | +5.43% since 01/27/23 |
| Low | 0.3600 on 01/31/23 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.48 on 02/02/23 | 732.49 on 01/30/23 |
| High | 0.4676 on 01/30/23 | 74.47 on 02/03/23 | 254.16 on 01/30/23 | 86.97 on 02/03/23 | 789.95 on 02/03/23 |
| 1-Month | |||||
| %Chg | +35.71% since 01/03/23 | +3.03% since 01/03/23 | -6.30% since 01/03/23 | -1.04% since 01/03/23 | +8.70% since 01/03/23 |
| Low | 0.2603 on 01/04/23 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.48 on 02/02/23 | 668.00 on 01/09/23 |
| High | 0.5900 on 01/19/23 | 75.00 on 01/24/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 789.95 on 02/03/23 |
| 3-Month | |||||
| %Chg | -15.56% since 11/03/22 | -5.14% since 11/03/22 | -7.79% since 11/03/22 | +6.34% since 11/03/22 | +6.02% since 11/03/22 |
| Low | 0.2601 on 12/30/22 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 78.39 on 11/04/22 | 668.00 on 01/09/23 |
| High | 0.5900 on 01/19/23 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 789.95 on 02/03/23 |
| 6-Month | |||||
| %Chg | unch since 08/03/22 | +2.00% since 08/03/22 | -0.80% since 08/03/22 | +35.70% since 08/03/22 | +28.64% since 08/03/22 |
| Low | 0.0706 on 10/12/22 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 60.62 on 08/05/22 | 572.22 on 09/06/22 |
| High | 0.5900 on 01/19/23 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 789.95 on 02/03/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,842 | 158,292,608 | 130,817,560 | 105,983,616 | 85,284,416 |
| Shares Outstanding, K | 49,583 | 2,126,160 | 533,579 | 1,254,244 | 108,902 |
| Annual Sales | 20,610,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | -15,950,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | 4,940,000 | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,936,200,000 |
| Last Quarter Net Income | -390,000 | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 1,315,700,000 |
| 60-Month Beta | 2.64 | 0.43 | 0.63 | 0.39 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 11/14/22 | 1.82 on 02/02/23 | 4.09 on 01/31/23 | 1.67 on 02/02/23 | 12.56 on 02/03/23 |
| Latest Earnings Date | 03/30/23 | 02/02/23 | 01/31/23 | 02/02/23 | 02/03/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 03/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.45 | 13.94 | 11.20 | 13.67 |
